Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients

about

Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients

Item

http://www.wikidata.org/entity/Q37023145

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Impact of Fluoroquinolone Expo ...... in Immunocompromised Patients

@en

Impact of Fluoroquinolone Expo ...... in Immunocompromised Patients.

@nl

type

Item

label

Impact of Fluoroquinolone Expo ...... in Immunocompromised Patients

@en

Impact of Fluoroquinolone Expo ...... in Immunocompromised Patients.

@nl

prefLabel

Impact of Fluoroquinolone Expo ...... in Immunocompromised Patients

@en

Impact of Fluoroquinolone Expo ...... in Immunocompromised Patients.

@nl

P1476

Impact of Fluoroquinolone Expo ...... in Immunocompromised Patients

@en

P2093

Hyun Jung Lee

http://www.w3.org/2001/XMLSchema#string

Ju Young Lee

http://www.w3.org/2001/XMLSchema#string

Jun Hee Woo

http://www.w3.org/2001/XMLSchema#string

Sang-Oh Lee

http://www.w3.org/2001/XMLSchema#string

Shinae Yu

http://www.w3.org/2001/XMLSchema#string

Sung-Han Kim

http://www.w3.org/2001/XMLSchema#string

Tae Sun Shim

http://www.w3.org/2001/XMLSchema#string

Yang Soo Kim

http://www.w3.org/2001/XMLSchema#string

Yong Kyun Kim

http://www.w3.org/2001/XMLSchema#string

Yong Pil Chong

http://www.w3.org/2001/XMLSchema#string

P2860

Fluoroquinolones for treating tuberculosis

Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas

Innate immunity to Mycobacterium tuberculosis.

Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.

Fluoroquinolones, tuberculosis, and resistance.

Clinical and radiographic features of pulmonary tuberculosis in non-AIDS immunocompromised patients.

Imaging of pulmonary tuberculosis.

Mycobacterium tuberculosis infection in recipients of solid organ transplants.

The risk of tuberculosis in patients with cancer.

Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia.

P304

4005-4012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01749-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sang-Ho Choi

Jiwon Jung

P577

2016-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27090178

http://www.w3.org/2001/XMLSchema#string

P932

4914627

http://www.w3.org/2001/XMLSchema#string